Fingerprint
Dive into the research topics of 'SPARC expression did not predict efficacy of nab-paclitaxel plus gemcitabine or gemcitabine alone for metastatic pancreatic cancer in an exploratory analysis of the phase III MPACT trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically